Covid testing system at risk of ‘collapse’ when travel reopens
Coronavirus tests for people in quarantine are routinely arriving late, warns consumer group

The UK’s coronavirus testing system for holidaymakers could “buckle” this summer as private labs are failing to keep up with demand.
Consumer group Which? has warned that Covid tests for people in quarantine are routinely arriving late, with passengers having to extend their isolation period or pay for additional Covid tests because of the delays.
With passenger numbers just a fraction of their usual levels due to restrictions on overseas travel, Which? says the system may not be able to “cope with demand” when international travel resumes to a limited number of countries on 17 May, says The Telegraph.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Travellers arriving in the UK must currently quarantine for a mandatory ten days and take a PCR test on day two and day eight of that period. These tests typically cost between £160 and £200, but can cost over £500. Test users must receive negative results for both these tests before they can leave quarantine on day ten of their isolation.
But Which? has said social media and review sites are already “flooded” with complaints from people who have suffered delays in receiving their test kits and results.
Holidaymakers could also be fined up to £2,000 if they fail to comply with government rules, reports Metro.
Some providers have pointed to delays with Royal Mail deliveries, but Royal Mail has said there are no delays in its network in relation to the use of priority postboxes for travellers’ test results.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rory Boland, editor of Which? Travel magazine, said: “The UK’s travel testing system can’t cope with demand, even when relatively small numbers of people are travelling,” the Independent reports.
“It’s clear the system could buckle under the pressure when mass international travel restarts and hundreds of thousands more people are reliant on it. Travellers shouldn’t have to shop around for something as crucial as a test provider. They simply need a service that is accessible, reliable and delivered on time.”
The Department of Health and Social Care told The Telegraph it was “carefully monitoring” any issues raised by the public, and was “raising every complaint” with private test providers.
“We also monitor all providers’ performance, including their delivery and test turnaround times. We will take rapid action against any company that is providing an inadequate service.
“In the first instance, they will receive a warning and are given five days to demonstrate they have addressed concerns, and if not, they are removed from the gov.uk list.”
-
What does 'conquering' Gaza mean to Israel?
Today's Big Question Benjamin Netanyahu's cabinet has approved a plan to displace much of the Palestinian population while seizing and occupying the territory on a long-term basis.
-
Casey Means: the controversial 'wellness influencer' nominated for surgeon general
In the Spotlight Means has drawn controversy for her closeness to RFK Jr.
-
Trump taps Fox News' Pirro for DC attorney post
speed read The president has named Fox News host Jeanine Pirro to be the top federal prosecutor for Washington, replacing acting US Attorney Ed Martin
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report